company background image
2172 logo

MicroPort NeuroTech SEHK:2172 Stock Report

Last Price

HK$7.52

Market Cap

HK$4.4b

7D

-10.4%

1Y

-46.6%

Updated

15 Jun, 2024

Data

Company Financials +

MicroPort NeuroTech Limited

SEHK:2172 Stock Report

Market Cap: HK$4.4b

2172 Stock Overview

Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.

2172 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 2172 from our risk checks.

MicroPort NeuroTech Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MicroPort NeuroTech
Historical stock prices
Current Share PriceHK$7.52
52 Week HighHK$14.46
52 Week LowHK$7.30
Beta0
1 Month Change-18.17%
3 Month Change-14.93%
1 Year Change-46.59%
3 Year Changen/a
5 Year Changen/a
Change since IPO-69.43%

Recent News & Updates

MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends

Apr 26
MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends

Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?

Mar 05
Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?

Recent updates

MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends

Apr 26
MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends

Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?

Mar 05
Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?

Returns On Capital At MicroPort NeuroTech (HKG:2172) Have Hit The Brakes

Jan 18
Returns On Capital At MicroPort NeuroTech (HKG:2172) Have Hit The Brakes

Calculating The Fair Value Of MicroPort NeuroTech Limited (HKG:2172)

Nov 04
Calculating The Fair Value Of MicroPort NeuroTech Limited (HKG:2172)

Shareholders Will Be Pleased With The Quality of MicroPort NeuroTech's (HKG:2172) Earnings

Sep 29
Shareholders Will Be Pleased With The Quality of MicroPort NeuroTech's (HKG:2172) Earnings

Investors Could Be Concerned With MicroPort NeuroTech's (HKG:2172) Returns On Capital

Aug 04
Investors Could Be Concerned With MicroPort NeuroTech's (HKG:2172) Returns On Capital

Shareholder Returns

2172HK Medical EquipmentHK Market
7D-10.4%0.9%-1.8%
1Y-46.6%-44.5%-3.7%

Return vs Industry: 2172 underperformed the Hong Kong Medical Equipment industry which returned -44.5% over the past year.

Return vs Market: 2172 underperformed the Hong Kong Market which returned -3.7% over the past year.

Price Volatility

Is 2172's price volatile compared to industry and market?
2172 volatility
2172 Average Weekly Movement5.5%
Medical Equipment Industry Average Movement7.0%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 2172's share price has been volatile over the past 3 months.

Volatility Over Time: 2172's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004571Zhiyong Xiewww.medneurotech.com

MicroPort NeuroTech Limited engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk; Tubridge, a flow-diverting stent; Willis, an intracranial stent graft system; Comaneci, an adjustable temporary coil embolization; and Rebridge, an intracranial visualized stent for use in the treatment of hemorrhagic stroke. It also offers NeuroGuard, NuFairy, a absorbable coil embolization system; and liquid embolic agent, a cerebral arteriovenous malformations.

MicroPort NeuroTech Limited Fundamentals Summary

How do MicroPort NeuroTech's earnings and revenue compare to its market cap?
2172 fundamental statistics
Market capHK$4.38b
Earnings (TTM)HK$156.71m
Revenue (TTM)HK$716.66m

28.0x

P/E Ratio

6.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2172 income statement (TTM)
RevenueCN¥665.62m
Cost of RevenueCN¥153.83m
Gross ProfitCN¥511.79m
Other ExpensesCN¥366.24m
EarningsCN¥145.55m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.25
Gross Margin76.89%
Net Profit Margin21.87%
Debt/Equity Ratio0%

How did 2172 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.